Containing eight new chapters which detail various pharmacoeconomic, regulatory, manufacturing, administration, and safety issues concerning new and emerging immunotherapy techniques, this third edition has been enlarged to describe more than a decade of advances in the immunotherapy of allergic diseases and asthma, and includes the most recent studies on the mechanisms, manufacture, and standardization of various allergen groups and their utilization in the treatment of allergic diseases.